Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Maitreya Medicare Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Maitreya Medicare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Maitreya Medicare - Change in Company Secretary/Compliance Officer
-
Maitreya Medicare - Appointment
-
Maitreya Medicare - Outcome of Board Meeting
-
Maitreya Medicare - Statement of deviation(s) or variation(s) under Reg. 32
-
Maitreya Medicare - Statement of deviation(s) or variation(s) under Reg. 32
-
Maitreya Medicare - Board Meeting Intimation
-
Maitreya Medicare - Resignation
-
Maitreya Medicare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Maitreya Medicare - General Updates
-
Maitreya Medicare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Maitreya Medicare - Related Party Transactions
-
Maitreya Medicare - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Maitreya Medicare - Trading Window-XBRL
-
Maitreya Medicare - Trading Window-XBRL
-
Maitreya Medicare - Trading Window
Key fundamentals
Evaluate the intrinsic value of Maitreya Medicare Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | |
|---|---|---|---|---|---|
| Assets | 34.3206 | 20.3702 | 17.3807 | 18.6144 | |
| Liabilities | 34.3206 | 20.3702 | 17.3807 | 18.6144 | |
| Equity | 6.776 | 4.96 | 0.01 | 0.01 | |
| Gross Profit | 6.1605 | 7.1456 | 2.9285 | 7.304 | |
| Net Profit | 3.1736 | 4.1855 | 1.0016 | 4.4097 | |
| Cash From Operating Activities | -0.2583 | 2.3828 | 0.6076 | 4.9077 | |
| NPM(%) | 6.82 | 10.87 | 2.07 | 7.81 | |
| Revenue | 46.528 | 38.4788 | 48.1967 | 56.4064 | |
| Expenses | 40.3675 | 31.3332 | 45.2682 | 49.1024 | |
| ROE(%) | 11.96 | 15.78 | 3.77 | 16.62 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Maitreya Medicare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 802.25 | -0.44 | 26.62 | 0.00 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 71.90 | -0.18 | 205.43 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 12.69 | -0.16 | 211.50 | 0.00 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 672.20 | -0.91 | 0.00 | 0.00 | -687.10 | 0.00 |
Company Info
Our company was originally formed and registered as a private limited company under Companies Act, 2013 in the name and style of `Maitreya Medicare Private Limited' vide certificate of incorporation dated 28th March, 2019 bearing Corporate Identification Number U24290GJ2019PTC107298 issued by the Registrar of Companies, Ahmedabad. Thereafter, our company was converted into a public limited company pursuant to a special resolution passed by our members at the Extra-Ordinary General Meeting held on March 06, 2023 and consequently the name of our company was changed to Maitreya Medicare Limited and a fresh certificate of incorporation was issued by Registrar of Companies, Ahmedabad dated March 30, 2023 bearing Corporate Identification Number U24290GJ2019PLC107298.Major events and milestones2019Established and commenced operations of our first Hospital at Surat, Gujarat2021Maitreya Medicare expanded for B Wing and converted into 125 beds from 100 beds.2022Obtained Certificate of Accreditation from National Accredation Board for Hospitals & Healthcare Providers (NABH)2023 Conversion of our Company from private limited to public limited
Our company was originally formed and registered as a private limited company under Companies Act, 2013 in the name and style of `Maitreya Medicare Private Limited' vide certificate of incorporation dated 28th March, 2019 bearing Corporate Identification Number U24290GJ2019PTC107298 issued by the Registrar of Companies, Ahmedabad. Thereafter, our company was converted into a public limited company pursuant to a special resolution passed by our members at the Extra-Ordinary General Meeting held on March 06, 2023 and consequently the name of our company was changed to Maitreya Medicare Limited and a fresh certificate of incorporation was issued by Registrar of Companies, Ahmedabad dated March 30, 2023 bearing Corporate Identification Number U24290GJ2019PLC107298.Major events and milestones2019Established and commenced operations of our first Hospital at Surat, Gujarat2021Maitreya Medicare expanded for B Wing and converted into 125 beds from 100 beds.2022Obtained Certificate of Accreditation from National Accredation Board for Hospitals & Healthcare Providers (NABH)2023 Conversion of our Company from private limited to public limited
Read More
Parent Organisation
Maitreya Medicare Ltd.
Founded
28/03/2019
Managing Director
Dr.Narendra Singh Tanwar
NSE Symbol
MAITREYASM
FAQ
The current price of Maitreya Medicare Ltd is
The 52-week high for Maitreya Medicare Ltd is
The market capitalization of Maitreya Medicare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Maitreya Medicare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Maitreya Medicare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Maitreya Medicare Ltd shares.
The CEO of Maitreya Medicare Ltd is Dr.Narendra Singh Tanwar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
